Codexis CDXS
NASDAQ CDXS
$1.67 +0.09 (+5.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Codexis (CDXS) Other Non Operating Income (2015 - 2026)

Codexis (CDXS) posted quarterly Other Non Operating Income of -$1.3 million for Q1 2026, down 36.94% year-over-year from -$2.0 million in Q1 2025, and up 19.17% quarter-over-quarter from -$1.6 million in Q4 2025.

Codexis (CDXS) Other Non Operating Income (2015 - 2026) Analysis & Trends

Codexis' Other Non Operating Income history runs 12 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

  • In Q1 2026, Other Non Operating Income fell 36.94% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$5.2 million (up 52.3% YoY), while the FY2025 annual figure was -$4.8 million, up 53.69% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at -$1.3 million, up from -$1.6 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $216000.0 in Q3 2022, with the low at -$8.3 million in Q4 2023.
  • The 5-year median for Other Non Operating Income is -$984000.0 (2025), against an average of -$1.7 million.
  • The sharpest annual moves came in 2022 and 2023: Other Non Operating Income jumped 96.59% in 2022, then sank 31992.31% in 2023.
  • Codexis' Other Non Operating Income stood at -$26000.0 in 2022, then tumbled by 31992.31% to -$8.3 million in 2023, then soared by 52.4% to -$4.0 million in 2024, then soared by 59.82% to -$1.6 million in 2025, then rose by 19.17% to -$1.3 million in 2026.
  • Business Quant data shows CDXS's Other Non Operating Income at -$1.3 million in Q1 2026, -$1.6 million in Q4 2025, and -$1.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Codexis 152.06 Mn 97.14 Mn 11.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.30 Mn
Mar 31, 2026 -1.29 Mn
Dec 31, 2025 -1.60 Mn
Sep 30, 2025 -1.29 Mn
Jun 30, 2025 -984,000.00
Mar 31, 2025 -942,000.00
Dec 31, 2024 -3.97 Mn
Sep 30, 2024 -4.92 Mn
Jun 30, 2024 -985,000.00
Mar 31, 2024 -516,000.00
Dec 31, 2023 -8.34 Mn
Sep 30, 2023 -3.90 Mn
Jun 30, 2023 -9,000.00
Mar 31, 2023 -25,000.00
Dec 31, 2022 -26,000.00
Sep 30, 2022 216,000.00
Jun 30, 2022 -63,000.00
Mar 31, 2022 -3,000.00
Dec 31, 2021 228,000.00
Sep 30, 2021 983,000.00